Piao, Chun Shu <br/><br/>
Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult.  [electronic resource] 

 -  Journal of neuroscience research  Aug 2003 
 - 537-44 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0360-4012 
<br/><br/><label>Standard No.: </label>10.1002/jnr.10671  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Astrocytes--drug effects<br/>Blotting, Western--methods<br/>Brain--drug effects<br/>Brain Infarction--metabolism<br/>Cyclooxygenase 2<br/>Cytokines--genetics<br/>Disease Models, Animal<br/>Gene Expression Regulation--drug effects<br/>Imidazoles--therapeutic use<br/>Immunohistochemistry--methods<br/>Infarction, Middle Cerebral Artery--physiopathology<br/>Isoenzymes--genetics<br/>Lectins--metabolism<br/>Male<br/>Microglia--drug effects<br/>Mitogen-Activated Protein Kinase 14<br/>Mitogen-Activated Protein Kinases--antagonists & inhibitors<br/>Neurologic Examination<br/>Nitric Oxide Synthase--genetics<br/>Nitric Oxide Synthase Type II<br/>Prostaglandin-Endoperoxide Synthases--genetics<br/>Pyridines--therapeutic use<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reverse Transcriptase Polymerase Chain Reaction--methods<br/>Tetrazolium Salts--metabolism<br/>Time Factors